Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-26-261719
Filing Date
2026-06-08
Accepted
2026-06-08 16:08:22
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFM14A d76493ddefm14a.htm DEFM14A 1629653
2 GRAPHIC g76493g01a01.jpg GRAPHIC 35766
3 GRAPHIC g76493g01a02.jpg GRAPHIC 36182
4 GRAPHIC g76493g02a02.jpg GRAPHIC 51870
5 GRAPHIC g76493g03a03.jpg GRAPHIC 33981
6 GRAPHIC g76493g04a04.jpg GRAPHIC 53287
7 GRAPHIC g76493g05a05.jpg GRAPHIC 33997
8 GRAPHIC g76493g07a07.jpg GRAPHIC 53366
9 GRAPHIC g76493g54i83.jpg GRAPHIC 200824
10 GRAPHIC g76493g74w69.jpg GRAPHIC 241624
  Complete submission text file 0001193125-26-261719.txt   2600449
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33057 | Film No.: 261072670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)